share_log

Goldman Sachs Maintains Buy on Guardant Health, Lowers Price Target to $28

Goldman Sachs Maintains Buy on Guardant Health, Lowers Price Target to $28

高盛維持對Guardant Health的買入,將目標股價下調至28美元
Moomoo 24/7 ·  04/15 10:25

Goldman Sachs analyst Matthew Sykes maintains Guardant Health (NASDAQ:GH) with a Buy and lowers the price target from $32 to $28.

高盛分析師馬修·賽克斯維持Guardant Health(納斯達克股票代碼:GH)的買入並將目標股價從32美元下調至28美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論